Intensity Therapeutics, Inc.

INTS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$3-$3-$3-$3
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$0$1
Change in WC-$0-$1$1-$0
Other Non-Cash$0$0$0-$0
Operating Cash Flow-$2-$2-$2-$3
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$7$4$0$3
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0-$1
Financing Cash Flow$7$4$0$2
Forex Effect$0$0$0$0
Net Chg. in Cash$5$1-$2-$0
Supplemental Information
Beg. Cash$2$1$3$3
End Cash$7$2$1$3
Free Cash Flow-$2-$2-$2-$3
Intensity Therapeutics, Inc. (INTS) Financial Statements & Key Stats | AlphaPilot